Clinical Trials on Muscular Dystrophy, Limb-Girdle Type 2 in Finland
Total 10 results
-
University of TurkuFazer; Aromtech Ltd.; Pakkasmarja; Saarioinen; Kiantama Ltd.; Satakunta Sea Buckthorn... and other collaboratorsCompletedAtherosclerosis | Type 2 DiabetesFinland
-
Paijat-Hame Hospital DistrictPfizer; Tampere University; Sitra, the Finnish Innovation FundUnknownHeart Failure | Coronary Disease | Diabetes Mellitus, Type 2Finland
-
South Karelia, Social and Health Care DistrictCompletedCoronary Artery Disease | Heart Failure | Atrial Fibrillation | Type 2 Diabetes | Other ArrhythmiasFinland
-
Markus PerolaUniversity of Helsinki; Institute for Molecular MedicineActive, not recruitingType 2 Diabetes | Coronary Heart Disease | Deep Vein ThrombosisFinland
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesAustralia, United States, Canada, Mexico, Puerto Rico, Germany, Hungary, Ireland, Poland, Romania, Denmark, Czech Republic, India, Colombia, Finland, United Kingdom
-
AstraZenecaBristol-Myers SquibbCompletedType 2 DiabetesMexico, Russian Federation, Spain, United States, Canada, Puerto Rico, Hungary, Peru, Romania, Poland, Germany, Czech Republic, India, Colombia, Denmark, Finland
-
Boehringer IngelheimCompletedHypertension | Diabetes Mellitus, Type 2United Kingdom, Denmark, Finland, Netherlands, Norway, Sweden
-
GlaxoSmithKlineCompletedHypertensionUnited States
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, France, Spain, Sweden, China, Korea, Republic of, United States, Canada, Germany, Ireland, Mexico, Poland, India, Denmark, Hungary, United Kingdom, New Zealand, Malaysia, Netherlands, Russian Federation, Thailand, Romania, Ita... and more
-
TakedaCompletedDiabetes Mellitus, Type 2 | Acute Coronary SyndromeUnited States, France, Italy, Poland, Ukraine, United Kingdom, Belgium, Germany, Hong Kong, Argentina, Chile, Colombia, Israel, Mexico, Portugal, Bulgaria, Malaysia, Romania, Serbia, South Africa, Japan, Canada, Finland, Taiwan, Korea,... and more